The primary regulatory authority for health products in Georgia is the National Agency for Pharmacy and Medical Technologies (NAMET), operating under the Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Affairs of Georgia. The principal governing legislation includes the Law of Georgia on Medicines and Pharmaceutical Activities and the Law of Georgia on Medical Devices, which together establish the legal framework for registration, licensing, and post-market surveillance of pharmaceuticals, medical devices, diagnostics, and related health technologies. The registration process requires applicants to submit a formal dossier to NAMET, which then conducts a technical and scientific review. Products approved by stringent regulatory authorities (SRAs) such as the EMA, US FDA, or Health Canada may benefit from an abbreviated or expedited review pathway, reflecting Georgia's policy of recognizing internationally accepted standards to reduce duplicative evaluation burden.
Key submission requirements include the appointment of a local authorized representative or legal entity registered in Georgia, who assumes regulatory responsibility for the product on the Georgian market. Dossiers are generally accepted in CTD (Common Technical Document) format, aligning Georgia with international harmonization norms. Labeling and product information must be provided in the Georgian language. Georgia has undertaken meaningful regulatory modernization efforts in recent years, including alignment with European Union regulatory principles as part of its EU Association Agreement obligations and the Deep and Comprehensive Free Trade Area (DCFTA) commitments. These reforms have progressively strengthened pharmacovigilance requirements, introduced stricter post-market controls, and promoted the adoption of Good Manufacturing Practice (GMP) standards consistent with EU and WHO guidelines.
Public procurement of health products in Georgia is centrally coordinated through the State Procurement Agency (SPA), operating in conjunction with the Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Affairs. Publicly funded health programs, including the Universal Health Care (UHC) program introduced in 2013, drive a significant volume of procurement for pharmaceuticals, diagnostics, and medical devices. Tender processes are governed by the Law of Georgia on State Procurement and are conducted through the electronic State Procurement Portal, which promotes transparency and open competition. Hospital-level and facility-level procurement may occur within framework agreements established at the national level, and certain essential medicines or strategic health commodities may be procured through centralized state contracts to ensure supply security and price efficiency.
The private sector constitutes a substantial share of the Georgian health market, with a competitive retail pharmacy network and a growing number of private hospitals and diagnostic centers procuring products independently through commercial channels and distributor relationships. Georgia also benefits from donor-funded procurement programs: the Global Fund to Fight AIDS, Tuberculosis and Malaria has historically supported procurement of diagnostics and treatment commodities for HIV and TB programs, while USAID and its implementing partners have provided technical and commodity assistance across various health verticals. UNICEF has supported maternal and child health supply chains, and WHO provides normative and technical guidance. Local manufacturing capacity in Georgia remains limited, and there are no extensive local manufacturing preference or offset policies comparable to those found in some larger markets; however, ongoing regional economic integration discussions and investment promotion initiatives may increasingly incentivize domestic production in the medium term.
This is a generic market overview. For a structured entry brief tailored to your product category, including regulatory pathway, pricing, and risk assessment, use the Market Brief tool.
Generate a free Market Brief for Georgia (Caucasus) →